Lovenox outsells Arixtra in the US market by 10:1, and hence the availability of a generic version of Arixtra should have little if any measurable impact on Lovenox.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”